Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyromonas Gingivalis: A Randomized, Triple-blind Clinical Trial

NCT06882564 is registered in ClinicalTrials.gov with Al-Mustansiriyah University as lead sponsor.

NCT NCT06882564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyromonas Gingivalis: A Randomized, Triple-blind Clinical Trial
Lead sponsor
Al-Mustansiriyah University
Phase
Phase 3
Overall status
Recruiting
Start date
January 5, 2025
Completion date
November 1, 2025
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding gum, halitosis, mouth disease, peridontal disease, plaque induced gingival disease